1MVU

single chain fv of c219 heavy chain v101l mutant in complex with synthetic epitope peptide

• Total interactions analyzed: 3
• Total true interactions: 3
• Strongest Interaction:
  • Chains: A-P
  • Int. Res.: 26
  • Norm. En. per Res.: -3.3712
• Hub Node: A(2)

All Interactions

Chains	Hydro. Bond Ener. (kJ/mol)	Elec. Ener. (kJ/mol)	VDW. Ener. (kJ/mol)	Tot. Stab. Ener. (kJ/mol)	#int. res.	# Short cont.	#Hydr. int.	#VDW pairs	#salt bridges	#Pot. fav. elec. int	#Pot. unfav. elec. int
A-B	-14.1638	-30.6181	-267.255	-312.0369	97	1	3	9685	4	13	9
A-P	-25.697	0.0	-61.9529	-87.6499	26	4	4	2389	0	2	2
B-P	-12.9857	-4.0957	-66.6051	-83.6865	33	1	3	3037	0	12	10

Interface residues

• A-B: ALA106A, ALA113B, ALA57A, ALA61B, ALA97B, ARG50B, ARG98B, ARG99B, ASN31A, ASN34A, ASN37A, ASN57B, ASN96A, ASP109B, ASP1A, ASP1A5, ASP52B, ASP97A, CB9.64831-3.91448, CYS94A, CYS96B, GLN35A, GLN39B, GLN43A, GLN43B, GLN44A, GLN48A, GLN6A, GLN6B, GLN95A, GLU100B, GLU42B, GLU46B, GLU61A, GLY105A, GLY107A, GLY112B, GLY114B, GLY33A, GLY44B, GLY47A, GLY49B, HIS35B, ILE48B, ILE54A, LEU102A, LEU108B, LEU39A, LEU45B, LEU4B, LEU52A, LEU53A, LYS109A, LYS36A, LYS38B, LYS45A, LYS51A, LYS59B, LYS63B, PHE104A, PHE33B, PHE64B, PRO101A, PRO107B, PRO46A, PRO49A, PRO50A, PRO62B, SER103B, SER106B, SER62A, SER99A, THR103A, THR40A, THR58B, THR59A, TRP111B, TRP36B, TRP41A, TRP47B, TRP56A, TYR100A, TYR104B, TYR105B, TYR38A, TYR42A, TYR55A, TYR60B, TYR92A, TYR93A, TYR94B, TYR95B, TYR98A, VAL110B, VAL37B, VAL91A, VAL93B
• A-P: ALA5P, ARG10P, ASN31A, ASN34A, ASN96A, ASP7P, ASP97A, GLN3P, GLN95A, GLU4P, GLY33A, ILE2A, LEU102A, LEU29A, LEU6P, LYS36A, PRO101A, SER32A, SER99A, THR103A, TRP56A, TYR100A, TYR38A, TYR98A, VAL1P, VAL2P
• B-P: ALA54B, ALA5P, ALA9P, ARG10P, ARG13P, ARG50B, ARG99B, ASN55B, ASN57B, ASP31B, ASP32B, ASP52B, ASP7P, GLN3P, GLU100B, GLU4P, GLY12P, HIS35B, LEU101B, LEU108B, LEU6P, LYS59B, LYS8P, PHE33B, PRO107B, SER103B, SER106B, TRP47B, TYR102B, TYR104B, TYR105B, VAL1P, VAL2P